We have previously identified that Sita (i.e., an DPP4 inhibitor) therapy significantly suppressed the DPP4 activity in circulation which, in turn, markedly increased circulating and tissue levels of SDF-1 and GLP-1 in setting of organ ischemia in rodent [29-32]
Injectable semaglutide is more effective for individuals who prefer faster results or are comfortable with self-injections, resulting in more consistent weight loss
J Clin Nutr Metab 1(1):2 Cueto R, Shen W, Liu L, Wang X, Wu S, Mohsin S et al (2024) SAH is a major metabolic sensor mediating worsening metabolic crosstalk in metabolic syndrome
h , Relative abundance of cecal metabolites, including short-chain fatty acids (SCFA), branched-chain amino acids (BCAA), tricarboxylic acid intermediates (TCAi), and metabolites involved in creatine synthesis, quantified by nuclear magnetic resonance (NMR)
These findings have expanded the use of GLP-1 agonists in diabetes management